Short and highly efficient synthetic promoters for melanoma-specific gene expression

FEBS Letters

Volumn 579, Issue 1, 2005, Pages 153-156

  Martinelli, Rosanna ^a   De Simone, Vincenzo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Expression vector; Gene therapy; Melanoma; Tyrosinase promoter

Indexed keywords

ALPHA FETOPROTEIN; MONOPHENOL MONOOXYGENASE; NUCLEAR FACTOR I; RECOMBINANT DNA; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

ALPHA-FETOPROTEINS; CELL LINE, TUMOR; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, REPORTER; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; PROMOTER REGIONS (GENETICS);

VECTORS;

EID: 11144265896     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.11.068     Document Type: Article

References (19)

1. R.G. Vile, S.J. Russel, and N.R. Lemoine Cancer gene therapy: hard lessons and new courses Gene Therapy 7 2000 2 8
2. F.L. Moolten Cancer Gene Ther. 1 1994 279 287
3. D.M. Pardoll Paracrine cytokine adjuvants in cancer immunotherapy Annu. Rev. Immunol. 13 1995 399 415
4. N. Miller, and J. Whelan Progress in transcriptionally targeted and regulatable vectors for genetic therapy Hum. Gene Ther. 8 1997 803 815
5. A. Korner, and J. Pawelek Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin Science 217 1982 1163 1165
6. V. Hearing, and K. Tsukamoto Enzymatic control of pigmentation in mammals FASEB J. 5 1991 2902 2909
7. P. Lowings, U. Yavuzer, and C.R. Goding Positive and negative elements regulate a melanocyte-specific promoter Mol. Cell. Biol. 12 1992 3653 3662
8. N. Bentley, T. Eisen, and C.R. Goding Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator Mol. Cell. Biol. 14 1994 7996 8006
9. K.I. Yasumoto, K. Yokoyama, K. Shibata, Y. Tomita, and S. Shibahara Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene Mol. Cell. Biol. 14 1994 8058 8070
10. K. Shibata, Y. Muraosa, Y. Tomita, H. Tagami, and S. Shibahara Identification of a cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene J. Biol. Chem. 267 1992 20584 20588
11. R.G. Vile, R.M. Diaz, N. Miller, S. Mitchell, A. Tuszynski, and S.J. Russel Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter Virology 214 1995 307 313
12. R.M. Diaz, T. Eisen, I.R. Hart, and R.G. Vile Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma J. Virol. 72 1998 789 795
13. W.M. Siders, P.J. Halloran, and R.G. Fenton Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus Cancer Gene Ther. 5 1998 281 291
14. G. Cao, X. Zhang, X. He, Q. Chen, and Z. Qi A safe, effective in vivo gene therapy for melanoma using tyrosinase promoter-driven cytosine deaminase gene In Vivo 13 1999 181 187
15. D.M. Nettelbeck, A.A. Rivera, C. Balague, R. Alemany, and D.T. Curiel Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter Cancer Res. 62 2002 4663 4670
16. N.S. Banerjee, A.A. Rivera, M. Wang, L.T. Chow, T.R. Broker, D.T. Curiel, and D.M. Nettelbeck Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures Mol. Cancer Ther. 3 2004 437 449
17. A. Demartis, R. Vignali, M. Maffei, G. Barsacchi, and V. De Simone Cloning and developmental expression of LFB3/HNF1 beta transcription factor in Xenopus laevis Mech. Dev. 47 1994 19 28
18. C. Chen, and H. Okayama High-efficiency transformation of mammalian cells by plasmid DNA Mol. Cell. Biol. 7 1987 2745 2752
19. M.G. Sotomayor, H. Yu, S. Antonia, E.M. Sotomayor, and D.M. Pardoll Advances in gene therapy for malignant melanoma Cancer Contr. 9 2002 39 48